Quick navigation menu :

  1. Go to main section's menu
  2. Go to Search tool
  3. Go to Help menu
  4. Go to modules
  5. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worlwide |
     
  2. Global Business Websites |
     
  3. Contact Us |
  4. Sitemap |
  5. Help
  1. Font size

    Reduce Increase  
 
 

About Us

Contact

Sanofi Bangladesh Limited

6/2/A Segun Bagicha
Dhaka 1000
Bangladesh

Tel. : +880 96 78 000 777
Fax : +880 2 955 0009

Content :

Our Company

Sanofi, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.

 

Sanofi is the one of world’s leading Pharmaceutical companies  and the largest in Europe.

Present in more than 100 countries, with around 11,000 scientists, we have around 100,000 employees working to improve health and wellbeing.

Our Global headquarters are in Paris, France

7 Major therapeutic areas

Sanofi focuses its activities on 7 major therapeutic areas:

Great Medicines for millions of patients

The Sanofi portfolio of marketed products includes several medicines that are world leaders in their respective classes, in the areas of thrombosis, cardiovascular disease, sleep disorders, epilepsy, diabetes and cancer.

In Bangladesh Sanofi markets Amaryl®, Actonel®, Clexane®, Eloxatin®, Epilim®, Fymoxyl®, Flagyl®, Frisium®, Lantus®, Profenid®, Sandom®, Sefrad®, Sefurox®, Stemetil®, Telfast®, Taxotere®, among other products. Vaccines are included in the product portfolio which represents names like TetavaxTM, VerorabTM, Euvax BTM, Typhim ViTM etc.

A highly productive and innovative R&D

With more than 25 research centres on three continents, Sanofi coordinates its Research and Development on a worldwide basis. The Sanofi annual R&D budget exceeds four billion euros and ranks among the three largest budgets of global pharmaceutical industry. Sanofi currently possesses one of the richest and most innovative portfolios in the industry with more than 100 molecules and vaccines in development, half of which are in advanced stages (phases II and III).

The group dedicates its research in finding innovative, effective and safe medicines that provide new therapeutic solutions to patients.

Module :

Corporate information

Corporate information

 

Muin Uddin Mazumder

Working towards what really matters: Health

Message from Muin Uddin Mazumder, Managing Director, Sanofi Bangladesh Limited